The Max Cure Fund For Pediatric Cancer Research, at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City, is dedicated to researching pediatric cancers, improving treatments and finding cures that will save children’s lives. The primary mission of The Max Cure Fund is to raise $5 Million to underwrite the establishment of a research laboratory at MSKCC in the Department of Pediatrics. The lab will be devoted to researching, treating and curing childhood cancers.

The Fund was established in June 2007 by the Plotkin family, in honor of their young son Maxwell Grant Plotkin, who was diagnosed with cancer on May 2, 2007 – one day before his fourth birthday. Eight days later, they learned Max’s cancer was an extremely rare form of B-Cell Lymphoma. It was every parent’s worst nightmare. Max’s cancer was so rare that doctors at MSKCC, one of the premier cancer treatment facilities in the world, had never seen it before. To complicate matters, it wasn’t a straight-forward case. The cancer had spread and the oncologists were blunt. Without the proper immediate treatment, the consequences would be devastating. Without delay, Max started a two-year protocol of intense chemotherapy at MSKCC, where he continues care, and Max’s family founded The Max Cure Fund.

The Max Cure Fund For Pediatric Cancer Research has already raised hundreds of thousands of dollars towards its goal and has been honored by organizations including Memorial Sloan-Kettering and The New York Rangers at Madison Square Garden.

  |   Maxx Media >>